In October 2019, the U.S. Food and Drug Administration approved Trikafta, a drug able to treat patients with the most common cystic fibrosis (CF) mutation. Approved for patients 12 and over, the drug means that more...
A Different Kind of Key
As society pushes the limits of technology, the battle between privacy and security is growing more intense. And the consequences are spilling out all over the headlines. In India, for example, widespread hysteria...
Greater Together
Two Spanish language professors — one a linguist, the other an expert in literature and translation — are enthusiastic if unlikely members of the James and Jean Culver Vision Discovery Institute (VDI), a group of...
Far from Inevitable
To understand the power of one vote, you don’t have to look much further than the one cast 100 years ago by Harry T. Burn in the Tennessee House of Representatives. That vote broke a stalemate which gave Tennessee, the...
Banking for the Future
If you’ve ever heard a Northerner and a Southerner discuss winter weather, you know that cold can be a relative term. But when Dr. Roni Bollag, director of the Georgia Cancer Biorepository, uses the term, he means it...
From the Wire: R&D 2020
Layman receives top reproductive medicine researcher award Dr. Lawrence C. Layman, chief of the Section of Reproductive Endocrinology, Infertility and Genetics in the Department of Obstetrics and Gynecology at the...
